Market Research Logo

Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020

Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020

Focus on cost effectiveness of therapeutic drug monitoring and increase in R&D investments will boost the growth of therapeutic drug monitoring market

The therapeutic drug monitoring market is projected to reach USD 2.55 billion by 2020 from USD 1.78 billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020).
In this report, the therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region.

North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutic drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure. Europe on the other hand is growing at a slower rate as the healthcare sector is recovering from the economic downturn and healthcare facilities are trying to minimize healthcare delivery costs. Growth in the APAC therapeutic drug monitoring market is comparatively slower due to the dearth of skilled healthcare personnel who can perform therapeutic drug monitoring tests with minimal errors.

From an insight perspective, this research report focuses on the qualitative data, future market size, share, and market potential of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and challenges) and technological trends in therapeutic drug monitoring. It mainly focuses on the emerging and high-growth segments of the therapeutic drug monitoring market and government initiatives across regions.

The competitive landscape covers the various strategies adopted by industry players to maintain their position in the therapeutic drug monitoring market. The company profiles comprise the basic views on the key players in the therapeutic drug monitoring market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares.

Reasons to buy this report:
This research report has focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth market segments; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on galley equipment offered by the top players in the global therapeutic drug monitoring market

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the therapeutic drug monitoring market

Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for therapeutic drug monitoring across regions

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global therapeutic drug monitoring market

Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global therapeutic drug monitoring market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • THERAPEUTIC DRUG MONITORING: MARKET OVERVIEW
    • GEOGRAPHICAL ANALYSIS: THERAPEUTIC DRUG MONITORING MARKET, BY CLASSES OF DRUG (2015)
    • GEOGRAPHICAL SNAPSHOT OF THE THERAPEUTIC DRUG MONITORING MARKET, 2015
    • THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY
    • THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET, BY TYPE
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
    • MARKET DYNAMICS
    • DRIVERS
      • ADVANCES IN DRUG PHARMACOKINETICS AND PHARMACOGENETICS TO INCREASE THE DEMAND FOR THERAPEUTIC DRUG MONITORING
      • USE OF TDM IN TRADITIONAL ANTICANCER THERAPIES
    • RESTRAINTS
      • LACK OF FINANCIAL PROVISION FOR CLINICAL INTERPRETATION OF TDM RESULTS
    • OPPORTUNITIES
      • ENABLING PERSONALIZED MEDICINE VIA THERAPEUTIC DRUG MONITORING WHILE REDUCING HEALTHCARE COSTS
    • CHALLENGES
      • DEARTH OF SKILLED PROFESSIONALS TO PERFORM TESTS AND INTERPRET RESULTS
  • THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT
    • INTRODUCTION
      • Table GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
    • THERAPEUTIC DRUG MONITORING CONSUMABLES
      • Table GLOBAL THERAPEUTIC DRUG MONITORING CONSUMABLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING CONSUMABLES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • THERAPEUTIC DRUG MONITORING EQUIPMENT
      • Table GLOBAL THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table GLOBAL THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • IMMUNOASSAY ANALYZERS
        • Table GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • PROTEOMICS TECHNOLOGIES
        • Table GLOBAL PROTEOMIC TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • OTHER EQUIPMENT
        • Table GLOBAL OTHER EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
    • IMMUNOASSAYS
      • Table IMMUNOASSAYS IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table IMMUNOASSAY IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • CHEMILUMINESCENT IMMUNOASSAY (CLIA)
        • Table CLIA IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • CLONED ENZYME DONOR IMMUNOASSAY (CEDIA)
        • Table CEDIA IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • FLUORESCENCE POLARIZATION IMMUNOASSAY (FPIA)
        • Table FPIA IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • PARTICLE-ENHANCED TURBIDIMETRIC-INHIBITION IMMUNOASSAY (PETINIA)
        • Table PETINIA IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • PROTEOMIC TECHNOLOGIES
      • Table PROTEOMIC TECHNOLOGIES IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table PROTEOMIC TECHNOLOGIES IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY (LC -MS)
        • Table LC-MS IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • GAS CHROMATOGRAPHY/MASS SPECTROMETRY (GC-MS)
        • Table GC-MS IN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table OTHER THERAPEUTIC DRUG MONITORING TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • THERAPEUTIC DRUG MONITORING MARKET, BY CLASS OF DRUG
    • INTRODUCTION
      • Table GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLASS OF DRUG, 2013-2020 (USD MILLION)
    • ANTIEPILEPTICS
      • Table GLOBAL ANTIEPILEPTICS MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: ANTIEPILEPTICS MONITORING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • ANTIARRHYTHMIC DRUGS
      • Table GLOBAL ANTIARRHYTHMIC DRUGS MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: ANTIARRHYTHMIC DRUGS MONITORING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • IMMUNOSUPPRESSANTS
      • Table GLOBAL IMMUNOSUPPRESSANTS MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOSUPPRESSANTS MONITORING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • ANTIBIOTICS
      • Table GLOBAL ANTIBIOTICS MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: ANTIBIOTICS MONITORING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • BRONCHODILATORS
      • Table GLOBAL BRONCHODILATORS MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: BRONCHODILATORS MONITORING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • PSYCHOACTIVE DRUGS
      • Table GLOBAL PSYCHOACTIVE DRUGS MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: PSYCHOACTIVE DRUGS MONITORING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • OTHER DRUG CLASSES
      • Table OTHER THERAPEUTIC DRUG CLASSES MONITORING MARKET SIZE , BY REGION, 2013-2020 (USD MILLION)
  • THERAPEUTIC DRUG MONITORING MARKET, BY END USER
    • INTRODUCTION
      • Table TDM MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • HOSPITAL LABS
      • Table TDM MARKET SIZE FOR HOSPITAL LABS, BY REGION, 2013-2020 (USD MILLION)
    • COMMERCIAL/PRIVATE LABS
      • Table TDM MARKET SIZE FOR COMMERCIAL/PRIVATE LABS, BY REGION, 2013-2020 (USD MILLION)
    • OTHER END USERS
      • Table TDM MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • GLOBAL THERAPEUTIC DRUG MONITORING MARKET, BY REGION
    • INTRODUCTION
      • Table THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, BY TYPE, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET SIZE FOR IMMUNOASSAYS, BY TYPE, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET SIZE FOR PROTEOMICS, BY TYPE, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLASS OF DRUG, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
      • U.S.
        • Table U.S.: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table U.S.: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
        • Table U.S.: THERAPEUTIC DRUG MONITORING MARKET SIZE FOR IMMUNOASSAYS, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: THERAPEUTIC DRUG MONITORING MARKET SIZE FOR PROTEOMICS, BY TYPE, 2013-2020 (USD MILLION)
        • Table U.S.: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLASS OF DRUG, 2013-2020 (USD MILLION)
        • Table U.S.: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
      • CANADA
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET SIZE FOR IMMUNOASSAYS, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET SIZE FOR PROTEOMICS, BY TYPE, 2013-2020 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLASS OF DRUG, 2013-2020 (USD MILLION)
        • Table CANADA: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • EUROPE
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET SIZE FOR IMMUNOASSAYS, BY TYPE, 2013-2020 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET SIZE FOR PROTEOMICS, BY TYPE, 2013-2020 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLASS OF DRUG, 2013-2020 (USD MILLION)
      • Table EUROPE: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • ASIA-PACIFIC
      • Table APAC: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table APAC: THERAPEUTIC DRUG MONITORING EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table APAC: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
      • Table APAC: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table ROW: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
      • Table ROW: THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • COMPETITIVE SITUATION AND TRENDS
      • NEW PRODUCT LAUNCHES, PRODUCT APPROVALS, AND PATENTS
        • Table NEW PRODUCT LAUNCHES, PRODUCT APPROVALS, AND PATENTS, 2012-2015
      • ACQUISITIONS
        • Table ACQUISITIONS, 2012-2015
      • MARKETING AND PROMOTIONS
        • Table MARKETING AND PROMOTIONS , 2012-2015
      • AGREEMENTS
        • Table AGREEMENTS, 2012-2015
      • OTHERS
        • Table OTHER DEVELOPMENTS, 2012-2015
  • COMPANY PROFILES
    • INTRODUCTION
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SIEMENS HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • THERMO FISHER SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • AGILENT TECHNOLOGIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BIOMÉRIEUX
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ALERE INC.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERED
      • RECENT DEVELOPMENTS
    • SEKISUI MEDICAL CO. LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report